Valmet (VALMT) AGM 2026 summary

Opening remarks and agenda

• Chairman welcomed shareholders, introduced the board, and outlined the meeting agenda, including technical instructions and voting procedures.

• Noted significant board changes over the past year and emphasized the importance of board diversity and competence.

Board and executive committee updates

• Board convened 13 times with a 95% attendance rate, focusing on strategy renewal and operating model updates.

• CEO Thomas Hinnerskov, in role for 19 months, was commended for energetic leadership and cultural transformation.

• Two board committees—Audit and People & Remuneration—oversaw sustainability, risk, and incentive plan renewals.

• Executive leadership team saw new appointments and departures, reflecting ongoing organizational renewal.

Financial performance review

• Orders received decreased 11% to EUR 5,216 million, mainly due to a tough comparison year in biomaterials.

• Net sales remained steady; comparable EBITDA margin reached a record 11.9%, up 60 basis points from 2024.

• EUR 35 million in cost savings realized from operating model changes, with EUR 80 million expected in total.

• Cash flow was strong at EUR 581 million; balance sheet remains solid with 35% gearing.

• Process Performance Solutions delivered a 19.6% margin, contributing 43% of EBITDA.